ArticleBMC pediatrics2026
Predictors of prognosis in children under six years of age with recurrent croup: a retrospective cohort study.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCroup is a common cause of upper respiratory tract obstruction in young children. Although most cases resolve spontaneously, some children experience recurrent attacks. Identifying prognostic factors that determine the risk of recurrence in children with recurrent croup may help optimize follow-up and treatment strategies. We aimed to investigate the clinical, demographic, and laboratory characteristics of children under six years of age with recurrent croup and to identify independent predictors of disease recurrence during a 6- and 12-month follow-up period.
methodsWe conducted a retrospective cohort study of 69 children (<6 years) diagnosed with recurrent croup at a single tertiary pediatric pulmonology and allergy–immunology center. Eligible subjects (≥2 clinician-documented episodes within 12 months) presented between October 2020 and October 2023 and had at least 12 months of follow-up. We gathered information from medical records about the children's background, health details, laboratory results, and treatments. Binary logistic regression was used to identify independent predictors of croup recurrence within the first 6 and 12 months.
resultsThe mean age was 4.4±1.5 years, and 67% (n=46) were male. Within 6 months, 40.6% of cases experienced at least one recurrent attack, and 11.6% experienced a croup attack between 6 and 12 months. For 6-month recurrence, a family history of atopy (OR: 7.50, 95% CI: 1.96–28.68; p=0.003) and a higher number of croup attacks before follow-up (OR: 1.43, 95% CI: 1.06–1.92; p=0.020) were independent predictors, but age and cough trigger were not significant. For 12-month recurrence, family history of atopy (OR: 9.11, 95% CI: 1.12–74.00; p=0.039) and the number of attacks prior to follow-up (OR: 1.66, 95% CI: 1.08–2.54; p=0.020) were significant, while advanced age emerged as a protective factor (OR: 0.48, 95% CI: 0.24–0.95; p=0.035). In a small, clinically selected subgroup, flexible optical bronchoscopy and thoracic CT angiography identified airway compression and laryngeal findings possibly consistent with reflux-related irritation.
conclusionsIn young children with recurrent croup, a family history of atopy and the number of prior croup episodes were independently associated with a higher probability of further recurrences during 6- and 12-month follow-up. These easily available clinical factors may help identify children who warrant closer follow-up, but validated risk thresholds and diagnostic pathways require prospective external validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.